Home › Funds › Artia Global Partners LP › VKTX
Artia Global Partners LP position in VKTX
VIKING THERAPEUTICS INC · Health Care
Artia Global Partners LP reported holding 180,731 shares of VKTX (VIKING THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$7.1M, representing 1.30% of its reported portfolio and ranking #17 among its reported holdings. Artia Global Partners LP has disclosed VKTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's VKTX position evolved
Artia Global Partners LP first disclosed a stake in VKTX in Q3 2023 at 383,580 shares (US$4.2M). The position peaked in Q1 2024 at 433,580 shares, worth US$35.6M. Across 12 filings, Artia Global Partners LP increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 180,731 shares valued at US$7.1M. Notable position changes include a 255% increase in Q3 2024 (shares fell 36% over the following quarter), a 83% trim in Q4 2024 (shares fell 40% over the following quarter), a 392% increase in Q4 2025 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 383.58K | $4.25M | New |
| Q4 2023 | 383.58K | $7.14M | Hold |
| Q1 2024 | 433.58K | $35.55M | Add |
| Q2 2024 | 150.00K | $7.95M | Reduce |
| Q3 2024 | 532.88K | $33.74M | Add |
| Q4 2024 | 90.28K | $3.63M | Reduce |
| Q1 2025 | 90.28K | $2.18M | Hold |
| Q2 2025 | 96.48K | $2.56M | Add |
| Q3 2025 | 146.18K | $3.84M | Add |
| Q4 2025 | 719.37K | $25.31M | Add |
| Q1 2026 | 180.73K | $5.88M | Reduce |
| Q2 2026 | 180.73K | $7.05M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VKTX and 13F data
VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VKTX
- Vestal Point Capital, LP 680.00K sh · $26.53M · Q2 2026
- Eversept Partners, LP 602.92K sh · $23.52M · Q2 2026
- ADAR1 Capital Management, LLC 574.04K sh · $22.39M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 500.00K sh · $19.50M · Q2 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held VKTX?
Artia Global Partners LP has disclosed VKTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Artia Global Partners LP's current position in VKTX?
As of Q2 2026, Artia Global Partners LP holds 180.73K shares of VKTX (VIKING THERAPEUTICS INC), valued at $7.05M, representing 1.30% of its reported portfolio and ranking #17.
Has Artia Global Partners LP been buying or selling VKTX?
In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in VKTX. The position peaked in Q1 2024 at 433.58K shares.
Which other funds hold VKTX?
Other major institutional holders of VKTX include Vestal Point Capital, LP, Eversept Partners, LP, ADAR1 Capital Management, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.